Elizabeth Gradelski

632 total citations
19 papers, 513 citations indexed

About

Elizabeth Gradelski is a scholar working on Molecular Medicine, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, Elizabeth Gradelski has authored 19 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Medicine, 13 papers in Pharmacology and 7 papers in Clinical Biochemistry. Recurrent topics in Elizabeth Gradelski's work include Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Elizabeth Gradelski is often cited by papers focused on Antibiotic Resistance in Bacteria (17 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Elizabeth Gradelski collaborates with scholars based in United States, Poland and Germany. Elizabeth Gradelski's co-authors include J Fung-Tomc, D P Bonner, E Huczko, Lourdes Valera, B Kolek, Beatrice Minassian, Lauren M. Aleksunes, R E Kessler, Terry M. Stickle and Thomas J. Dougherty and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Elizabeth Gradelski

19 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Gradelski United States	13	261	260	135	129	118	19	513
B Kolek United States	13	307 1.2×	294 1.1×	173 1.3×	206 1.6×	89 0.8×	16	637
Barbara LeBlanc United States	15	364 1.4×	305 1.2×	131 1.0×	177 1.4×	124 1.1×	45	629
Karen Amsler United States	10	233 0.9×	231 0.9×	257 1.9×	157 1.2×	140 1.2×	15	593
M. Husson Belgium	13	205 0.8×	176 0.7×	175 1.3×	165 1.3×	96 0.8×	35	499
Larissa Lutz Brazil	11	204 0.8×	331 1.3×	158 1.2×	151 1.2×	120 1.0×	24	581
C. J. Henwood United Kingdom	7	115 0.4×	281 1.1×	164 1.2×	110 0.9×	113 1.0×	7	462
Silvana Vargas Superti Brazil	11	168 0.6×	256 1.0×	118 0.9×	156 1.2×	88 0.7×	20	437
Mel DeCorby Canada	8	110 0.4×	216 0.8×	130 1.0×	130 1.0×	90 0.8×	11	412
P. Hohl Switzerland	11	260 1.0×	232 0.9×	271 2.0×	231 1.8×	97 0.8×	26	578
Michael J. Rybak United States	10	161 0.6×	181 0.7×	269 2.0×	97 0.8×	130 1.1×	18	610

Countries citing papers authored by Elizabeth Gradelski

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Gradelski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Gradelski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Gradelski more than expected).

Fields of papers citing papers by Elizabeth Gradelski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Gradelski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Gradelski. The network helps show where Elizabeth Gradelski may publish in the future.

Co-authorship network of co-authors of Elizabeth Gradelski

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Gradelski. A scholar is included among the top collaborators of Elizabeth Gradelski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Gradelski. Elizabeth Gradelski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Clark, Junius M., J Fung-Tomc, Beatrice Minassian, et al.. (2002). In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Organisms other than Staphylococci. Antimicrobial Agents and Chemotherapy. 46(4). 1108–1111. 1 indexed citations

Fung-Tomc, J, Elizabeth Gradelski, Lourdes Valera, E Huczko, & D P Bonner. (2002). Synergistic activity of the novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species. International Journal of Antimicrobial Agents. 20(1). 57–60. 8 indexed citations

Gradelski, Elizabeth. (2002). Bactericidal mechanism of gatifloxacin compared with other quinolones. Journal of Antimicrobial Chemotherapy. 49(1). 185–188. 22 indexed citations

Fung-Tomc, J, Junius M. Clark, Beatrice Minassian, et al.. (2002). In Vitro and In Vivo Activities of a Novel Cephalosporin, BMS-247243, against Methicillin-Resistant and -Susceptible Staphylococci. Antimicrobial Agents and Chemotherapy. 46(4). 971–976. 41 indexed citations

Fung-Tomc, J, Elizabeth Gradelski, E Huczko, Beatrice Minassian, & D P Bonner. (2001). Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants. International Journal of Antimicrobial Agents. 18(1). 77–80. 15 indexed citations

Gradelski, Elizabeth, Lourdes Valera, B Kolek, D P Bonner, & J Fung-Tomc. (2001). Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and β-lactams. International Journal of Antimicrobial Agents. 18(1). 43–48. 13 indexed citations

Gradelski, Elizabeth, Lourdes Valera, Lauren M. Aleksunes, D P Bonner, & J Fung-Tomc. (2001). Correlation between Genotype and Phenotypic Categorization of Staphylococci Based on Methicillin Susceptibility and Resistance. Journal of Clinical Microbiology. 39(8). 2961–2963. 46 indexed citations

Gradelski, Elizabeth, Lourdes Valera, D P Bonner, & J Fung-Tomc. (2001). Synergistic Activities of Gatifloxacin in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa and Related Species. Antimicrobial Agents and Chemotherapy. 45(11). 3220–3222. 14 indexed citations

Gradelski, Elizabeth, B Kolek, D P Bonner, et al.. (2001). Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents. International Journal of Antimicrobial Agents. 17(2). 103–107. 34 indexed citations

10.

Fung-Tomc, J, Elizabeth Gradelski, Lourdes Valera, B Kolek, & D P Bonner. (2000). Comparative Killing Rates of Fluoroquinolones and Cell Wall-Active Agents. Antimicrobial Agents and Chemotherapy. 44(5). 1377–1380. 23 indexed citations

11.

Fung-Tomc, J, Beatrice Minassian, B Kolek, et al.. (2000). Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756. Antimicrobial Agents and Chemotherapy. 44(12). 3351–3356. 142 indexed citations

12.

Fung-Tomc, J, Karen Bush, Beatrice Minassian, et al.. (1997). Antibacterial activity of BMS-180680, a new catechol-containing monobactam. Antimicrobial Agents and Chemotherapy. 41(5). 1010–1016. 27 indexed citations

13.

Fung-Tomc, J, Elizabeth Gradelski, E Huczko, et al.. (1996). Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy. 40(5). 1289–1293. 54 indexed citations

14.

Kessler, R E, J Fung-Tomc, B Kolek, et al.. (1995). In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity. Antimicrobial Agents and Chemotherapy. 39(2). 380–385. 10 indexed citations

15.

Fung-Tomc, J, E Huczko, Jacques Banville, et al.. (1995). Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 39(2). 394–399. 16 indexed citations

16.

Fung-Tomc, J, Elizabeth Gradelski, B Kolek, et al.. (1995). Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2. Antimicrobial Agents and Chemotherapy. 39(2). 386–393. 10 indexed citations

17.

Gradelski, Elizabeth, J Fung-Tomc, E Huczko, & R E Kessler. (1993). Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutations. Journal of Antimicrobial Chemotherapy. 32(suppl B). 75–80. 23 indexed citations

18.

Mastalerz, Harold, et al.. (1992). The synthesis, antibacterial, and .BETA.-lactamase inhibitory activity of a novel asparenomycin analog.. The Journal of Antibiotics. 45(2). 240–245. 4 indexed citations

19.

Fung-Tomc, J, E Huczko, Elizabeth Gradelski, et al.. (1991). Emergence of homogeneously methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology. 29(12). 2880–2883. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact